The Exchange has sought clarification from Glenmark Pharmaceuticals with reference to the news article in Financial Express July 29, 2015 captioned ‘Glenmark Pharmas skin gel infringes patent, says US court’.
The above information is a part of company’s filings submitted to BSE.